- Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's disease
- Interrogating DNA methylation associated with Lewy body pathology in a cross brain-region and multi-cohort study
- Uncovering synaptic and cellular nanoarchitecture of brain tissue via seamless <em>in situ</em> trimming and milling for cryo-electron tomography
- Dual-mode sensing platform based on an iodide ion synergistic covalent triazine frameworks (CTFs) for point-of-care testing (POCT) of acetylcholinesterase
- Statistical analysis of correlated expression data from high throughput experiments
- 1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases?
- The glymphatic system in Huntington's disease
- Emerging roles of microglia and neuroinflammation in Huntington's disease: From pathophysiology to clinical trials
- Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders
- Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
- Flavonoids in the regulation of microglial-mediated neuroinflammation; focus on fisetin, rutin, and quercetin
- Flavonoids and their role in oxidative stress, inflammation, and human diseases
- Profiling Swallowing Safety and Physiology in People With Huntington's Disease
- Potential targets of microglia in the treatment of neurodegenerative diseases: mechanism and therapeutic implications
- ONT in Clinical Diagnostics of Repeat Expansion Disorders: Detection and Reporting Challenges
- A TMT-Based Proteomic Analysis of Osmoregulation in the Gills of <em>Oreochromis mossambicus</em> Exposed to Three Osmotic Stresses
- Heat shock proteins in protein folding and reactivation
- Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review
- Communicating Genetic Information in Families with Inherited Late-Onset Neurodegenerative Diseases: A Scoping Review
- Compositional data modeling of high-dimensional single cell RNA-seq (CoDA-hd): its advantages over commonly used normalization approaches
- Time-restricted eating in early-stage Huntington's disease: A 12-week interventional clinical trial protocol
- The Art of Neuroregeneration De Novo and In Situ
- Identification and characterization of potent and selective inhibitors for the B0AT2/SLC6A15 amino acid transporter
- Unraveling Berberine's Molecular Mechanisms in Neuroprotection against Neurodegeneration
- Use of Paliperidone Long-Acting Injections in Huntington's Disease
- Inhibition of Mitochondrial Dynamics by Mitochondrial Division Inhibitor-1 Suppresses Cell Migration and Metastatic Markers in Colorectal Cancer HCT116 Cells
- Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington's disease chorea: A dual-site analysis
- Dual inhibition of canonical and noncanonical PAR-1 by SCH79797 mitigates neurodegeneration in 3-NP-induced Huntington's disease: An in vivo and in silico approach
- Brain-Derived Neurotrophic Factor (BDNF) in Huntington's Disease: Neurobiology and Therapeutic Potential
- The glymphatic system
- Plasma gangliosides correlate with disease stages and symptom severity in Huntington disease carriers
- Uncontrolled CAG expansion in neurons susceptible to Huntington's disease
- Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases
- Humanized rodent models of neurodegenerative diseases and other brain disorders
- Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides
- Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons
- Factors affecting the physical stability of peptide self-assembly in neurodegenerative disorders
- Education Level and Huntington's Disease Progression: A Retrospective Cohort Analysis in Western China
- Memantine-induced delayed sleep phase in Huntington's disease: A case report
- Errors in the Huntington's disease gene accumulate slowly and then all at once
- Antidepressants and Slower Disease Progression in Huntington's Disease
- Antidopaminergic Medications and Clinical Changes in Measures of Huntington's Disease: A Causal Analysis
- Cell Type-Specific Studies of Human Tissue for Investigation of the Molecular Cell Biology of Late-Onset Neurodegenerative Disease
- Structural-functional analyses of the huntingtin/HAP40 complex in <em>Drosophila</em> and humans
- Presymptomatic targeted circuit manipulation for ameliorating Huntington's disease pathogenesis
- In vivo mapping of striatal microstructure in Huntington's disease with Soma and Neurite Density Imaging
- Transcriptomic analysis of intracellular RNA granules and small extracellular vesicles: Unmasking their overlap in a cell model of Huntington's Disease
- Developmental alterations of indirect-pathway medium spiny neurons in mouse models of Huntington's disease
- Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington disease
- Neurodegenerative diseases: Epigenetic regulatory mechanisms and therapeutic potential
- Co-Activation Patterns in Neonates using High-Density Diffuse Optical Tomography: Insights into Early Dynamic Functional Connectivity
- The Adequacy of Vancomycin Initial Dosing in CRBSI for Hemodialysis Patients at Hospital Pakar Sultanah Fatimah, Muar, Johor
- Associations between Cardiovascular Risk Factors and Neurofilament Light Levels Among U.S. Mexican American Adults
- The breaking point where repeat expansion triggers neuronal collapse in Huntington's disease
- Early Alterations of Motor Learning and Corticostriatal Network Activity in a Huntington's Disease Mouse Model
- CAG Repeat Instability and Region-Specific Gene Expression Changes in the SCA12 Brain
- Unraveling the Roles of UBE3A in Neurodevelopment and Neurodegeneration
- Progress in AAV-Mediated In Vivo Gene Therapy and Its Applications in Central Nervous System Diseases
- Targeting cGAS-STING signaling: a potential therapeutic approach for the management of Huntington's disease
- Anle138b ameliorates pathological phenotypes in mouse and cellular models of Huntington's disease
- Modulation of autism-associated serotonin transporters by palmitoylation: Insights into the molecular pathogenesis and targeted therapies for autism spectrum disorder
- Corrigendum to "Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease" [Neurobiology of Disease 108 (2017) Pages 29-44]
- Age-Related Neurodegenerative Diseases: A Stem Cell's Perspective
- Local modulation of sleep slow waves depends on timing between auditory stimuli
- Electroacupuncture Neural Stimulation Mitigates Bladder Dysfunction and Mechanical Allodynia in Cyclophosphamide Induced Cystitis through Downregulation of the BDNF-TrkB Signaling Pathway
- Intersecting impact of CAG repeat and Huntingtin knockout in stem cell-derived cortical neurons
- Seven Hub Genes Associated with Huntington's Disease and Diagnostic and Therapeutic Potentials Identified by Computational Biology
- SNAP-25: A biomarker of synaptic loss in neurodegeneration
- Biallelic genome engineering to create isogenic induced pluripotent stem cells modelling Huntington's disease
- Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot study
- The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease
- Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity
- Unraveling progressive verbal memory deficits in Huntington's disease: insights from the LASSI-L
- ASO targets DNA repair protein to combat Huntington disease
- Downregulation of Pten Improves Huntington's Disease Phenotype by Reducing Htt Aggregates and Cell Death
- Protective effects of diacerein against quinolinic acid-induced Huntington's disease-like symptoms in adult zebrafish by targeting GSK-3beta signalling
- Spiritual Well-Being and Phenoconversion in Huntington's Disease: Analysis from the Prospective Huntington at Risk Observational Study
- Nonlinear Assessment of Gait Signal Complexity in Neurodegenerative Disorders
- Systemic Neuroprotection by Chlorogenic Acid: Antioxidant and Anti-inflammatory Evaluation in Early Neurodegeneration Induced by 3-Nitropropionic Acid in Mice
- Unnatural foldamers as inhibitors of Aβ aggregation <em>via</em> stabilizing the Aβ helix
- Action impulsivity and attention deficits in patients at an early stage of Huntington disease
- Advanced strategies for enhancing the neuroprotective potential of curcumin: delivery systems and mechanistic insights in neurodegenerative disorders
- Topological Gait Analysis: A New Framework and Its Application to the Study of Human Gait
- CellFIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology
- Sleep fragmentation, 24-hr rest-activity patterns, and cognitive function in premanifest Huntington's disease: An actigraphy study
- Allelic Diversity, de novo CAG Expansions, and Intergenerational Instability at the HTT Locus in a clinical sample of Huntingtons Disease from India
- Daily variation in symptoms and functioning in Huntington disease: Feasibility and variability
- Synergistic neuroprotective and cognitive-enhancing effects of Walnut Peptide and Theanine in human brain organoid and mouse stress models
- The effect of a single session of tDCS on attention in pediatric acquired brain injury: Characterising inter-individual structural and functional network response variability
- Recent Progress of Triplex DNA Formation and Its Applications
- Neuraxial Analgesia and Anesthesia for Labor and Cesarean Delivery in a Patient with Juvenile Huntington Disease: A Case Report
- Cost Trends of New-To-Market Neurologic Medications: An Insurance Claims Database Analysis
- Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential
- Upcoming meetings related to Huntington's disease
- Tandem repeat expansions and copy number variations as risk factors and diagnostic tools for amyotrophic lateral sclerosis
- Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NFqB in neurodegenerative disease
- The Role of Amphibian AMPs Against Oxidative Stress and Related Diseases
- Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective
- Transcriptome Study in Sicilian Patients with Huntington's Disease
- Analysis of Short Tandem Repeat Expansions in a Cohort of 12,496 Exomes from Patients with Neurological Diseases Reveals Variable Genotyping Rate Dependent on Exome Capture Kits
RSS Feed – Literature
HDinHD > RSS Feed – Literature
